hexamethylene bisacetamide has been researched along with sb 415286 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gu, Q; Liu, B; Su, L; Wang, Z; Wei, M; Yang, Z; Yao, H; Yu, Y; Zhang, Q; Zhu, Z | 1 |
1 other study(ies) available for hexamethylene bisacetamide and sb 415286
Article | Year |
---|---|
P27(Kip1), regulated by glycogen synthase kinase-3β, results in HMBA-induced differentiation of human gastric cancer cells.
Topics: Acetamides; Aminophenols; Antineoplastic Agents; Biomarkers, Tumor; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p27; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Intestinal Mucosa; Maleimides; Proton Pumps; Stomach Neoplasms | 2011 |